Drug Shortage Report for MIFEGYMISO
Report ID | 15501 |
Drug Identification Number | 02444038 |
Brand name | MIFEGYMISO |
Common or Proper name | Mifepristone / Misoprostol |
Company Name | LINEPHARMA INTERNATIONAL LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MISOPROSTOL MIFEPRISTONE |
Strength(s) | 200MCG 200MG |
Dosage form(s) | KIT TABLET |
Route of administration | BUCCAL ORAL |
Packaging size | Combipack (1 box of 1 tablet of mifepristone 200 mg tablet + 1 box of 4 tablets of 200 µg misoprostol) |
ATC code | G03XB |
ATC description | OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-07-10 |
Actual start date | 2017-07-10 |
Estimated end date | 2017-07-18 |
Actual end date | 2017-10-13 |
Shortage status | Resolved |
Updated date | 2017-11-10 |
Company comments | Linepharma International Limited considers that this shortage situation has a very low impact on public health since product is due to be made available in less than one week in Canada. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16 UPPER WOBURN PLACE LONDON, GREATER LONDON UNITED KINGDOM WC1H0BS |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-07-12 | English | Compare |
v2 | 2017-07-12 | French | Compare |
v3 | 2017-11-10 | English | Compare |
v4 | 2017-11-10 | French | Compare |
Showing 1 to 4 of 4